Connection

Michelle Willicombe to Pandemics

Back to Details
This is a "connection" page, showing publications Michelle Willicombe has written about Pandemics.
Michelle Willicombe
Connection Strength
0.034
Pandemics
  1. Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection. Kidney Int. 2021 06; 99(6):1470-1477.
    View in: PubMed
    Score: 0.008
  2. Authors' Reply. J Am Soc Nephrol. 2020 12; 31(12):2967-2968.
    View in: PubMed
    Score: 0.008
  3. High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening. J Am Soc Nephrol. 2020 09; 31(9):1969-1975.
    View in: PubMed
    Score: 0.007
  4. COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm? J Am Soc Nephrol. 2020 Jun; 31(6):1145-1146.
    View in: PubMed
    Score: 0.007
  5. Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Apr 12; 22(1):270.
    View in: PubMed
    Score: 0.002
  6. Anti-glomerular basement membrane disease during the COVID-19 pandemic. Kidney Int. 2020 09; 98(3):780-781.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.